An update to the 2016 guidelines has been issued, promoting greater flexibility for individualized patient-centered care.
An update to the 2016 guidelines has been issued, promoting greater flexibility for individualized patient-centered care.
A new report from the CDC found that 10% of overdose deaths in 2019-2020 involved gabapentin.
Proposed changes are open to public comment until April 11th.
New five-day rules are recommended, with variation depending upon vaccination status.
The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.
A joint statement announces that at this time, vaccinated adults are protected from the Delta variant.
After reviewing six rare cases of blood clots after 7 million doses, current data indicates the vaccine is safe.
The AMA suggests that prescription medications are no longer a significant factor in the opioid epidemic, and that opioid prescription limits should change.
A new JAMA study finds that increased county-level opioid marketing was tied to elevated overdose mortality.
Healthesystems’ clinical leaders comment on the collective responsibility of healthcare entities, providers, and legislators to increase efforts that will help stem opioid overprescribing, misuse and overdose.
